Top accelerator startups

Startups14,448Programs29

14,448 startups · 29 programs

Ochre Bio

Active · RNA medicines for liver diseases

WebsiteYC profile

Why it ranks

How the rank works
16signal of 100 · rising 3
  • team of 50Team size · YC's directory+8.9
  • went through YCProgram · this site+4
  • 2 programsMore than one program · this site+3

A sum of public facts, not a judgement and not investment advice.

Competitors

OtherHepatxShared: chronic liver, liver disease, biotechYC S18BendStartup →AIAltay TherapeuticsShared: chronic liver, liver disease, biotechYC W20San FranciscoStartup →OtherAcquiredLuminist LabsShared: liver disease, genomicsYC W16New York CityStartup →OtherSigma GeneticsShared: genomics, biotech, rnaYC W17SeattleStartup →OtherSerna BioShared: biotech, rna, medicineYC W21San FranciscoStartup →
Companies closest to Ochre Bio
Company
HepatxShared: chronic liver, liver disease, biotechYC S18ActiveOther
Altay TherapeuticsShared: chronic liver, liver disease, biotechYC W20ActiveAI
Luminist LabsShared: liver disease, genomicsYC W16AcquiredOther
Sigma GeneticsShared: genomics, biotech, rnaYC W17ActiveOther
Serna BioShared: biotech, rna, medicineYC W21ActiveOther

Adjacent

OtherAerskaShared: rna medicine, developing rna, diseaseEF 2025ExternalStartup →OtherHeptaShared: liver diseasePlug and PlayUnited StatesStartup →OtherRNAReviveShared: liver disease, rna, biotechnologyPlug and PlayCanadaStartup →OtherInactiveGerostate AlphaShared: biotech, disease, chronicYC S18San FranciscoStartup →AIBlank BioShared: rna, medicine, diseaseYC S25San FranciscoStartup →
Companies next to Ochre Bio
Company
AerskaShared: rna medicine, developing rna, diseaseEF 2025Not statedOther
HeptaShared: liver diseasePlug and Play Not statedOther
RNAReviveShared: liver disease, rna, biotechnologyPlug and Play Not statedOther
Gerostate AlphaShared: biotech, disease, chronicYC S18InactiveOther
Blank BioShared: rna, medicine, diseaseYC S25ActiveAI

Also from W20

All of W20
AIAlgen BiotechnologiesUsing CRISPR to find treatments for cancer and inflammationYC W20San FranciscoStartup →AIUrbanKisaanFoundation models and autonomous chambers for plant biologyYC W20HyderabadStartup →AIAbalone BioWe create activating antibodies to treat diseases others can’t.YC W20San FranciscoStartup →AIAccordThe Revenue Excellence PlatformYC W20San FranciscoStartup →AIAdenOpen source agent generation frameworkYC W20San FranciscoStartup →AIAIOSThe world’s first full-stack AI doctorYC W20San FranciscoStartup →
Company
Algen BiotechnologiesUsing CRISPR to find treatments for cancer and inflammationteam of 17ActiveAI
UrbanKisaanFoundation models and autonomous chambers for plant biologyteam of 53ActiveAI
Abalone BioWe create activating antibodies to treat diseases others can’t.team of 14ActiveAI
AccordThe Revenue Excellence Platformteam of 20hiringActiveAI
AdenOpen source agent generation frameworkteam of 5ActiveAI, Devtools
AIOSThe world’s first full-stack AI doctorteam of 100hiringActiveAI

Programs

Programs Ochre Bio went through
ProgramCohortSource
Y CombinatorW20YC Page
Entrepreneur First2019EF Page

About Ochre Bio

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

YC batch
W20 · Winter 2020
Status, per YC
Active
Category
Other
Team size
50
Location
London, England, United Kingdom; Oxford, England, United Kingdom
Checked
10h ago

YC tags: Biotech, Genomics

Ochre Bio in W20: 229 companies, 29% AI

Ochre Bio: questions

Which YC batch was Ochre Bio in?

Ochre Bio was in Y Combinator's Winter 2020 batch (W20).

Which accelerators did Ochre Bio go through?

Ochre Bio is listed by Y Combinator (W20), Entrepreneur First (2019).

Is Ochre Bio still active?

Y Combinator lists Ochre Bio as active.

Where is Ochre Bio based?

Ochre Bio lists London, England, United Kingdom; Oxford, England, United Kingdom as its location on YC's directory.